Calamos Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.41M | Buy |
|
|||||
|
2025
Q2 | $1.56M | Buy |
|
|||||
|
2025
Q1 | $1.7M | Sell |
|
|||||
|
2024
Q4 | $1.61M | Buy |
|
|||||
|
2024
Q3 | $1.75M | Buy |
|
|||||
|
2024
Q2 | $1.4M | Sell |
|
|||||
|
2024
Q1 | $1.59M | Sell |
|
|||||
|
2023
Q4 | $1.65M | Sell |
|
|||||
|
2023
Q3 | $1.79M | Buy |
|
|||||
|
2023
Q2 | $1.56M | Buy |
|
|||||
|
2023
Q1 | $1.79M | Buy |
|
|||||
|
2022
Q4 | $1.66M | Sell |
|
|||||
|
2022
Q3 | $1.38M | Sell |
|
|||||
|
2022
Q2 | $1.88M | Buy |
|
|||||
|
2022
Q1 | $1.98M | Buy |
|
|||||
|
2021
Q4 | $1.24M | Sell |
|
|||||
|
2021
Q3 | $998K | Sell |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $490K | Buy |
|
|||||
|
2020
Q4 | $364K | Buy |
|
|||||
|
2020
Q3 | $204K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $204K | Sell |
|
|||||
|
2019
Q3 | $222K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $270K | Sell |
|
|||||
|
2018
Q4 | $1.36M | Sell |
|
|||||
|
2018
Q3 | $5.15M | Sell |
|
|||||
|
2018
Q2 | $5.41M | Sell |
|
|||||
|
2018
Q1 | $6.18M | Buy |
|
|||||
|
2017
Q4 | $1.38M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.77M | Buy |
|
|||||
|
2015
Q4 | $1.02M | Sell |
|
|||||
|
2015
Q3 | $1.06M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $328K | Sell |
|
|||||
|
2014
Q4 | $412K | Buy |
|